Maplebear Inc
For the period ended Sep 30, 2024. Filed Nov 13, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 13, 2024
CART$58.47+0.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| Nine Months Ended September 30, | ||
|---|---|---|
| 2023 | 2024 | |
| OPERATING ACTIVITIES | ||
| Net income (loss) | $(1,757) | $309 |
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ||
| Depreciation and amortization expense | 33 | 39 |
| Stock-based compensation expense | 2,614 | 214 |
| Provision for bad debts | 18 | 16 |
| Amortization of operating lease right-of-use assets | 11 | 9 |
| Deferred income taxes | (394) | 55 |
| Other | (3) | 2 |
| Changes in operating assets and liabilities, net of effects of business acquisitions: | ||
| Accounts receivable | (17) | (112) |
| Prepaid expenses and other assets | 14 | (7) |
| Accounts payable | (31) | (3) |
| Accrued and other current liabilities | (108) | 18 |
| Deferred revenue | 22 | 13 |
| Operating lease liabilities | (11) | (12) |
| Other long-term liabilities | (38) | (7) |
| Net cash provided by operating activities | 353 | 534 |
| INVESTING ACTIVITIES | ||
| Purchases of marketable securities | (90) | (25) |
| Maturities of marketable securities | 274 | 54 |
| Purchases of property and equipment, including capitalized internal-use software | (38) | (52) |
| Other investing activities | — | (3) |
| Net cash provided by (used in) investing activities | 146 | (26) |
| FINANCING ACTIVITIES | ||
| Proceeds from the issuance of common stock upon initial public offering, net of underwriting discounts | 401 | — |
| Proceeds from the issuance of Series A redeemable convertible preferred stock | 175 | — |
| Taxes paid related to net share settlement of equity awards | (570) | (92) |
| Proceeds from exercise of stock options | 3 | 76 |
| Changes in advances from payment card issuer | — | 57 |
| Deferred offering costs paid | (3) | — |
| Repurchases of common stock | — | (1,397) |
| Net cash provided by (used in) financing activities | 6 | (1,356) |
| Effect of foreign exchange on cash, cash equivalents, and restricted cash and cash equivalents | — | (4) |
| Net increase (decrease) in cash, cash equivalents, and restricted cash and cash equivalents | 505 | (852) |
| Cash, cash equivalents, and restricted cash and cash equivalents - beginning of period | 1,599 | 2,293 |
| Cash, cash equivalents, and restricted cash and cash equivalents - end of period | $2,104 | $1,441 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS, CONTINUED
| Nine Months Ended September 30, | ||
|---|---|---|
| 2023 | 2024 | |
| SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION | ||
| Cash paid for income taxes, net of tax refunds | $40 | $13 |
| SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES | ||
| Stock-based compensation capitalized as internal-use software | $41 | $27 |
| Conversion of redeemable convertible preferred stock to common stock in connection with initial public offering | $2,822 | $— |
| Reclassification of deferred offering costs to additional paid-in capital upon initial public offering | $9 | $— |
| Changes in accrued purchases of property and equipment, including capitalized internal-use software | $3 | $(2) |
| Deferred offering costs not yet paid | $3 | $— |
| Accretion of Series A redeemable convertible preferred stock | $— | $7 |
| RECONCILIATION OF CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AND CASH EQUIVALENTS TO THE CONDENSED CONSOLIDATED BALANCE SHEETS | ||
| Cash and cash equivalents | $2,010 | $1,288 |
| Restricted cash and cash equivalents, current | 75 | 134 |
| Restricted cash and cash equivalents, noncurrent | 19 | 19 |
| Total cash, cash equivalents, and restricted cash and cash equivalents | $2,104 | $1,441 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.